APH vs EW · P/E 40, rev $23.09B vs P/E 47, rev $1.39B
Amphenol Corporation (APH) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
APH currently screens at market cap $170.77B and trailing P/E 39.9. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the APH and EW stock pages for the full models.
Not investment advice.